Stockscreener 앱 받기
108.28
0.06%
0.06
시간 외 거래:
108.31
0.03
+0.03%
Gilead Sciences Inc 주식(GILD)의 최신 뉴스
After Gilead Deal, Hookipa Hangs Up Its Hat - insights.citeline.com
Gilead Sciences Inc. Stock Analysis and ForecastMarket-leading growth rates - jammulinksnews.com
What drives Gilead Sciences Inc. stock priceExtraordinary market timing - Autocar Professional
Gilead’s HIV Strength Drives Gains, But Pipeline Is Key - Finimize
Why Gilead Sciences (GILD) Appeals to Income Investors in the Pharma Sector - MSN
Is Gilead Sciences Inc. a good long term investmentFree Wealth Planning Blueprint - Jammu Links News
Lobbying Update: $90,000 of GILEAD SCIENCES INC. lobbying was just disclosed - Quiver Quantitative
What analysts say about Gilead Sciences Inc. stockRapid wealth multiplication - jammulinksnews.com
HOOKIPA Pharma Inc. Announces Intent to Voluntarily Delist from Nasdaq and Pursue Asset Sale with Gilead Sciences - Quiver Quantitative
HOOKIPA Pharma Exits Nasdaq Market as Gilead Sciences Acquires Key Drug Programs - Stock Titan
Foster City drugs giant Gilead to pay $202 million over alleged kickback scheme - SiliconValley.com
Pennsylvania to receive $1.2M from Gilead over kickback scheme to promote HIV drugs - WPXI
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc.GILD - PR Newswire
Attorney General Ellison helps secure $200M from Gilead for paying illegal kickbacks - Red Lake Nation News
Gilead Sciences Inc. Agrees to $202 Million Settlement Over Kickbacks, Illinois Leads Charge with Multi-State Coalition - Hoodline
Gilead To Pay $202 Million In Nationwide Settlement Over Illegal HIV Drug Kickback Scheme - MyChesCo
Gilead Sciences CFO Dickinson sells $277k in stock By Investing.com - Investing.com South Africa
Gilead reaches $202M settlement over kickback scheme to promote HIV drug - Crain's New York Business
Troy Griffin on Gilead’s mission at Chosen Few picnic - rollingout.com
Why Merck Is A Better Dividend Stock Than Gilead Sciences (NYSE:MRK) - Seeking Alpha
Nevada to receive over $440K from Gilead settlement over alleged illegal kickbacks - KTVN
Gilead Sciences Advances in Triple-Negative Breast Cancer Treatment - TipRanks
Minnesota and Iowa join $202M Gilead settlement over kickbacks - KIMT
New York AG Letitia James Clinches Monumental $202M Victory Against Gilead Sciences Over HIV Med Kickbacks - Hoodline
Attorney General Raoul Announces More Than $200 Million Settlement With Gilead Sciences Over Illegal Kickbacks To Providers For Prescriptions - RiverBender.com
Pennsylvania to Receive Over $1.2 Million in HIV Drug Kickback Settlement with Gilead - Franklin County Free Press
AG Sunday Part of National Coalition Securing $200M+ from Gilead Sciences for Illegal Kickback Scheme to Sell HIV Drugs - exploreJefferson
GILD Investors Have Opportunity to Join Gilead Sciences, Inc. Fraud Investigation with the Schall Law Firm - WV News
Gilead’s Vítor Papão on key partnerships and the role of tech in public health - Gulf Business
Attorney General Bonta Helps Secure Over $200 Million from Gilead Sciences for Paying Illegal KickbacksState of California - State of California - Department of Justice (.gov)
Here's Why Gilead Sciences (GILD) Fell More Than Broader Market - Yahoo Finance
Tamar Braxton partners with Gilead for HIV awareness - Rolling Out
Sector Update: Health Care - MarketScreener
Pennsylvania to receive $1.28 million in settlement over Gilead’s illegal HIV drug kickback scheme - WTAJ
Tamar Braxton & Gilead Partner For PrEP Promo To Black Women - Black America Web
Gilead Sciences Reaches $202 Million Settlement Over Kickback Scheme Promoting HIV Drugs - MarketScreener
Pennsylvania Part of National Coalition Securing $200M+ from Gilead Sciences for Illegal Kickback Scheme to Sell HIV Drugs - pennwatch.org
Pennsylvania expected to get $1.28 million from biopharma company for violating anti-kickback laws - ABC27
Massachusetts Secures $1.6 Million from Gilead in $202 Million Multi-State Settlement Over HIV Drug Kickbacks - Hoodline
Gilead reaches $202M settlement over HIV drug speaker program - Seeking Alpha
Tamar Braxton Partners with Gilead to Empower Black Women on HIV Prevention - ThisisRnB.com
Bernstein Maintains Buy Rating on Gilead Sciences (GILD) Stock - Insider Monkey
Gilead Beats Defamation Suit by Worker Accused of Sex Harassment - Bloomberg Law News
Fighting Disease Requires More Than Just the Right Drug: Gilead - Mexico Business News
Gilead Sciences (GILD) Reaches Deal to Offer HIV Vaccine to Low and Middle-Income Nations - MSN
Gilead, GSK/ViiV, Merck Present New HIV PrEP Frontiers at IAS25 - BioSpace
Attorney General Schwalb Recovers Over $300,000 from Gilead Sciences for Illegal Kickback Scheme - District of Columbia | Attorney General (.gov)
How the Inhaled Antibiotics Market Will Evolve by 2032Growth, - openPR.com
Gilead's twice-yearly HIV PrEP set for wider rollout - pharmaphorum
Gilead’s twice-yearly HIV prevention shot effective across diverse groups By Investing.com - Investing.com Nigeria
Q1 Earnings Roundup: Gilead Sciences (NASDAQ:GILD) And The Rest Of The Therapeutics Segment - Yahoo Finance
Yeztugo's Double-Edged Sword: Gilead's HIV Breakthrough and the Global Stakes - AInvest
Gilead Presents New Data on Twice-Yearly Lenacapavir (Yeztugo®) for HIV Prevention at IAS 2025 - BioSpace
0.86%
0.38%
자본화:
|
볼륨(24시간):